Large gap with delayed quotes
|
Last quote
08/30/2025
-
02:00:00
|
Bid
08/29/2025 -
21:59:59
|
Bid Volume |
Ask
08/29/2025 -
21:59:59
|
Ask Volume |
|---|---|---|---|---|
|
139.60
+0.66
(
+0.48% )
|
139.55
|
600 |
139.61
|
300 |
Analysis date: 29.08.2025
Global Evaluation
Positive
Positive
The stock is classified in the positive zone since 29.08.2025.
Interest
Very strong
Very strong
Four stars since 26.08.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 01.08.2025 at a price of 128.91.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 15.08.2025.
4wk Rel Perf
2.63%
2.63%
The four-week dividend-adjusted overperformance versus SP500 is 2.63%.
Sensibility
Low
Low
The stock has been on the low-sensitivity level since 29.08.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.54%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.43%.
Mkt Cap in $bn
13.85
13.85
With a market capitalization >$8bn, NEUROCRINE BIOSCIENCES is considered a large-cap stock.
G/PE Ratio
2.01
2.01
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
10.13
10.13
The estimated PE is for the year 2029.
LT Growth
20.40%
20.40%
The annualized growth estimate is for the current year to 2029.
Avg. Nb analysts
17
17
Over the last seven weeks, an average of 17 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
78
78
For 1% of index variation, the stock varies on average by 0.78%.
Correlation
0.40
0.40
Stock movements are strongly independent of index variations.
Value at Risk
16.75
16.75
The value at risk is estimated at USD 16.75. The risk is therefore 12.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002